跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,469 条关于
“TILT Holdings”
全部
1,469
临床试验
406
药物
136
机构
151
资讯
776
2年前
TILT Biotherapeutics Presents Promising Clinical Data on Intravenous TILT-123 at ESMO 2024
去年
Curaleaf International Secures EU Medical Device Certification for Pioneering Cannabis Inhalation Technology
去年
TILT Biotherapeutics Advances TILT-123 Immunotherapy with Positive Clinical Trial Data
去年
TILT Biotherapeutics Secures $25.6M Series B to Advance Novel Oncolytic Virus Therapy for Ovarian Cancer
去年
Sareum's SDC-1801 Advances to Phase II Trials for Psoriasis Following Positive Phase I Results
去年
European Commission Approves Novo Holdings' $16.5B Catalent Acquisition
2年前
Bio-Path Holdings' BP1003 Demonstrates Therapeutic Potential in Diverse Cancers
7个月前
China Medical System Partners with Insilico Medicine for AI Drug Discovery, Advances Complement Inhibitor to Clinical Trials
2年前
Immunocore and Bristol Myers Squibb Collaborate on Phase 3 Trial for Advanced Cutaneous Melanoma
去年
ALX Oncology's Evorpacept Shows Promise in Multiple Cancer Trials
第 1 页,共 78 页
上一页
下一页